ASTANCOLLE, Serenella
 Distribuzione geografica
Continente #
NA - Nord America 2.655
EU - Europa 864
AS - Asia 291
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 3.814
Nazione #
US - Stati Uniti d'America 2.643
GB - Regno Unito 343
SE - Svezia 150
CN - Cina 119
DE - Germania 112
SG - Singapore 93
UA - Ucraina 74
IT - Italia 58
FI - Finlandia 47
HK - Hong Kong 30
FR - Francia 28
TR - Turchia 28
BG - Bulgaria 25
IN - India 15
CA - Canada 12
BE - Belgio 10
RU - Federazione Russa 8
NL - Olanda 2
PL - Polonia 2
RO - Romania 2
TH - Thailandia 2
AR - Argentina 1
AT - Austria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IR - Iran 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 3.814
Città #
Fairfield 350
Southend 266
Woodbridge 261
Chandler 256
Ann Arbor 169
Ashburn 168
Houston 168
Jacksonville 162
Santa Clara 151
Seattle 123
Wilmington 120
Cambridge 104
Nyköping 104
Dearborn 95
Singapore 76
Modena 32
San Diego 31
Fremont 30
Hong Kong 30
New York 29
Princeton 27
Eugene 25
Sofia 25
Beijing 23
Helsinki 23
Izmir 21
Falls Church 17
Bremen 14
Des Moines 11
Redwood City 11
Brussels 10
London 9
Toronto 9
Shanghai 8
Boardman 7
Hefei 6
San Mateo 6
Auburn Hills 5
Munich 5
Nanjing 5
Norwalk 4
Augusta 3
Dallas 3
Hounslow 3
Kilburn 3
Leawood 3
Milan 3
Parma 3
Philadelphia 3
Bangalore 2
Chongqing 2
Dongguan 2
Frankfurt am Main 2
Grafing 2
Guangzhou 2
Islington 2
Jinan 2
Kolkata 2
Kraków 2
Los Angeles 2
Marburg 2
Monmouth Junction 2
Ottawa 2
San Giuliano Milanese 2
Taiyuan 2
Amsterdam 1
Ardabil 1
Bagnolo San Vito 1
Bhavnagar 1
Bologna 1
Brno 1
Buenos Aires 1
Castelnuovo Rangone 1
Delhi 1
Denver 1
Dublin 1
Genova 1
Hangzhou 1
Hanover 1
Indiana 1
Karachi 1
Kiev 1
Kuala Lumpur 1
Kunming 1
Lawrence 1
Maceió 1
Markham 1
Mountain View 1
Mumbai 1
Nanchang 1
Saint Petersburg 1
Sant'Ilario d'Enza 1
Shenyang 1
Stockholm 1
Taipei 1
Tappahannock 1
Tauranga 1
Washington 1
Xian 1
Yinchuan 1
Totale 3.087
Nome #
Cisplatin-resistance modulates the effect of protein synthesis inhibitors on spermidine/spermine N-1-acetyltransferase expression 234
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 216
Differential induction of spermidine/spermine N1-acetyltransferase activity in cisplatin-sensitive and -resistant ovarian cancer cells in response to N1,N12-bis (ethyl)spermine involves transcriptional and post-transcriptional regulation. 210
Prognostic role of clusterin in resected adenocarcinomas of the lung. 199
Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin 191
Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing 187
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression 178
Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides 178
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer 173
Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts 170
Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts 161
Gene expression analysis in combination with clinical parameters is effective in predicting relapse after radical prostatectomy 154
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 153
Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression 150
Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment 146
LIVER ORNITHINE DECARBOXYLASE ACTIVITY IN THE EUROPEAN SEA BASS (DICENTRARCHUS LABRAX L.):EFFECTS OF PROTEIN COMPOSITION OF THE DIET,ENVIRONMENTAL CONDITIONS AND AGE 137
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression 130
Clusterin is down-regulated during the progression of prostate cancer in the tramp mouse model but up-regulated during chemioprevention by green tea catechins administration 125
Clusterin gene expression is down-regulated in transformed epithelial cells but up-regulated in fibroblasts from prostate cancer 120
GENE RELAXATION AND AGING - CHANGES IN THE ABUNDANCE OF RAT VENTRAL PROSTATE SGP-2 (CLUSTERIN) AND ORNITHINE DECARBOXYLASE MESSENGER-RNAS 116
CADMIUM INDUCTION OF RENAL AND HEPATIC ORNITHINE DECARBOXYLASE ACTIVITY IN THE RAT - EFFECTS OF SEX-HORMONES AND INVOLVEMENT OF THE RENIN-ANGIOTENSIN SYSTEM 112
Effects of CLU knock down on prostate cancer progression in the TRAMP model. 112
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 99
Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens (vol 60, pg 28, 2000) 99
BLOCKADE OF ALFA AND BETA-ADRENERGIC RECEPTORS CAN PREVENT STIMULATION OF LIVER ORNITHINE DECARBOXYLASE ACTIVITY BY GLUCOCORTICOID AND LAPARATOMY 97
Totale 3.847
Categoria #
all - tutte 17.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020590 0 0 0 0 82 116 126 69 85 21 46 45
2020/2021600 40 38 50 44 69 28 40 90 17 113 42 29
2021/2022519 5 84 54 33 15 18 33 19 45 27 117 69
2022/2023576 64 76 44 75 56 93 3 66 55 2 11 31
2023/2024227 10 16 18 14 51 40 7 18 6 7 29 11
2024/2025303 42 9 21 77 154 0 0 0 0 0 0 0
Totale 3.847